Tag Archives: medical countermeasures

The U.S. Department of Health and Human Services recently entered a contract with CUBRC, Inc., to aid in the development of a novel antibiotic to be used to treat the effects of biological warfare agents such as anthrax and plague. … Read More

SIPP International Industries, Inc., recently announced the acquisition of new technology to fight global bioterrorism. SIPP International’s Cell Robotics Imaging Work Station is capable of remotely identifying, isolating and studying pathogenic bioterror agents, such as anthrax, smallpox and botulism. The … Read More